<DOC>
	<DOC>NCT00882466</DOC>
	<brief_summary>The purpose of this study is to investigate the effect of intravenous human recombinant erythropoietin on the reperfusion injury at primary percutaneous coronary intervention in patients with acute myocardial infarction.</brief_summary>
	<brief_title>The Effect of Erythropoietin at the Time of Reperfusion in Acute Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Acute myocardial infarction &lt;12hr Age &gt;18yrs First myocardial infarction culprit lesion : proximal to mid left anterior descending artery Baseline coronary flow : TIMI Grade 0~1 Patients with previous myocardial infarction History of thrombotic complication History of cerebral infarction Uncontrolled hypertension Increased hemoglobin level &gt;17g/dL Patients with mechanical valve Cardiogenic shock</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>erythropoietin</keyword>
</DOC>